Description of Collaborative Activity: |
This collaboration is a bi-annual meeting to enhance communication between the Cancer Imaging Program (CIP) and the Division of Medical Imaging Products of the Center for Drug Evaluation and Research (CDER) in the Food and Drug Administration (FDA). This allows for a two-way exchange of information and discussion of issues that are important for each side. Topics that have been discussed include CIP's standardization efforts of medical imaging scanners in the National Cancer Institute's (NCI) Cancer Centers, presentation and discussion of specific new molecular imaging modalities, and discussion of recent FDA decisions regarding newmedical imaging innovations. |
